Chinese company Beijing Xinzhida Neurotechnology unveiled a brain computer interface (BCI) implant to rival Elon Musk’s Neuralink at the 2024 Zhongguancun Forum (ZGC Forum).
The ZGC Forum is an annual event attended by tech companies and researchers from over 40 countries. The event is held in northwest Beijing, which is home to over 17,000 tech companies.
Go deeper with GlobalData
The news was first reported by state-run news agency Xinhua.
The implant, named Neucyber, is reported to have been tested on monkeys, allowing them to control a robotic arm.
Xinhua reported that Neucyber had been “independently developed” by Beijing Xinzhida Neurotechnology.
The technology has not yet been subject to human trials.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataNeuralink only received FDA approval for human clinical trials in May 2023. In February 2024, the company announced that a human participant had been able to use a computer mouse using the implant.
BCI implants could give autonomy to patients who may be unable to move or speak for themselves.
However, BCI implant technology has sparked controversy due to its potential for data privacy leaks, ethical concerns and its risky implantation procedure that could lead to infection.
In March 2024, BCI implant companies created an industry group to build trust with regulators and the public.
Before BCI technology becomes widespread, data privacy, commercialisation and ethics will need to be addressed to foster consumer trust.
